Type I interferons in anticancer immunity

L Zitvogel, L Galluzzi, O Kepp, MJ Smyth… - Nature Reviews …, 2015 - nature.com
Type I interferons (IFNs) are known for their key role in antiviral immune responses. In this
Review, we discuss accumulating evidence indicating that type I IFNs produced by …

Cytokines and costimulation in acute graft-versus-host disease

GR Hill, M Koyama - Blood, The Journal of the American …, 2020 - ashpublications.org
Allogeneic hematopoietic stem cell transplantation (alloSCT) is an important curative
therapy for high-risk hematological malignancies, but the development of severe and/or …

A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients

C Li, YP Phoon, K Karlinsey, YF Tian… - Journal of Experimental …, 2021 - rupress.org
Immune checkpoint inhibitor (ICI) therapy continues to revolutionize melanoma treatment,
but only a subset of patients respond. Major efforts are underway to develop minimally …

Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease

A Swimm, CR Giver, Z DeFilipp… - Blood, The Journal …, 2018 - ashpublications.org
The intestinal microbiota in allogeneic bone marrow transplant (allo-BMT) recipients
modulates graft-versus-host disease (GVHD), a systemic inflammatory state initiated by …

Cytokines in graft-versus-host disease

AS Henden, GR Hill - The Journal of Immunology, 2015 - journals.aai.org
Graft-versus-host disease (GVHD) is a complication of allogeneic bone marrow
transplantation whereby transplanted naive and marrow-derived T cells damage recipient …

RIG-I/MAVS and STING signaling promote gut integrity during irradiation-and immune-mediated tissue injury

JC Fischer, M Bscheider, G Eisenkolb, CC Lin… - Science translational …, 2017 - science.org
The molecular pathways that regulate the tissue repair function of type I interferon (IFN-I)
during acute tissue damage are poorly understood. We describe a protective role for IFN-I …

ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease

J Zhang, AM Ramadan, B Griesenauer, W Li… - Science translational …, 2015 - science.org
Graft-versus-host disease (GVHD) remains a devastating complication after allogeneic
hematopoietic cell transplantation (HCT). We previously identified high plasma soluble …

Harnessing the immune system in acute myeloid leukaemia

R Austin, MJ Smyth, SW Lane - Critical reviews in oncology/hematology, 2016 - Elsevier
Acute myeloid leukaemia (AML) is an aggressive blood cancer caused by the proliferation of
immature myeloid cells. The genetic abnormalities underlying AML affect signal transduction …

Identification and expansion of highly suppressive CD8+FoxP3+ regulatory T cells after experimental allogeneic bone marrow transplantation

RJ Robb, KE Lineburg, RD Kuns… - Blood, The Journal …, 2012 - ashpublications.org
FoxP3+ confers suppressive properties and is confined to regulatory T cells (Treg) that
potently inhibit autoreactive immune responses. In the transplant setting, natural CD4+ Treg …

The yin and yang of type I IFNs in cancer promotion and immune activation

M Musella, C Galassi, N Manduca, A Sistigu - Biology, 2021 - mdpi.com
Simple Summary The crucial immune stimulatory functions exerted by Type I Interferons
(IFNs) in cancer settings have been not only widely demonstrated during the last fifty years …